Table 2 Patient and tumor characteristics
From: Increased expression of hypoxia-inducible factor 1α in type I and type II endometrial carcinomas
Type I | Type II | P-value | |
---|---|---|---|
No. of patients | 108 (72.5%) | 41 (27.5%) | |
Age (mean±s.d.) | 61.0±11.0 | 67.4±12.5 | 0.00 |
Race | |||
Caucasian | 76 (70%) | 22 (54%) | 0.054 |
African-American | 32 (30%) | 19 (46%) | |
Stage a | |||
I | 84 (78%) | 17 (44%) | <0.001 |
II | 8 (7%) | 5 (13%) | |
III | 12 (11%) | 14 (33%) | |
IV | 1 (1%) | 5 (10%) | |
No data available | 3 (3%) | 0 | |
Outcome | |||
Alive | 83 (77%) | 20 (49%) | 0.001 |
Dead | 24 (22%) | 21 (51%) | |
No data available | 1 (1%) | 0 | |
Histologic grade (FIGO) | |||
1 | 42 (39%) | N/A | |
2 | 47 (43.5%) | ||
3 | 19 (17.5%) | ||
Depth of invasion | |||
None | 31 (29%) | 8 (7%) | 0.047 |
Inner | 42 (39%) | 15 (33%) | |
Outer | 28 (26%) | 18 (60%) | |
No data available | 7 (6%) | 0 | |
Vascular invasion | |||
Yes | 41 (39%) | 25 (61%) | 0.015 |
No | 64 (59%) | 15 (37%) | |
No data available | 3 (2%) | 1 (2%) | |
Adnexal invasion | |||
Yes | 9 (8%) | 13 (31%) | 0.002 |
No | 96 (89%) | 28 (69%) | |
No data available | 3 (3%) | 0 |